United States Interventional Cardiology Market Outlook to 2033 - Coronary Stents, PTCA Balloon Catheters, Structural Heart Occlusion Devices and Others

1.1 List of Tables
1.2 List of Figures

2.1 What Is This Report About?
2.2 Interventional Cardiology Market Segmentation
2.3 Definitions of Markets Covered in the Report

3.1 Interventional Cardiology Market, United States, Revenue ($m), 2018-2033
3.1.1 Coronary Stents Market, United States, Revenue ($m), by Segment, 2018-2033
3.1.2 Intravascular Ultrasound Systems (IVUS) Market, United States, Revenue ($m), by Segment, 2018-2033
3.1.3 PTCA Balloon Catheters Market, United States, Revenue ($m), by Segment, 2018-2033
3.1.4 Structural Heart Occlusion Devices Market, United States, Revenue ($m), by Segment, 2018-2033
3.1.5 Transcatheter Accessories Market, United States, Revenue ($m), by Segment, 2018-2033
3.2 Interventional Cardiology Market, United States, Volume (Units), 2018-2033
3.2.1 Coronary Stents Market, United States, Volume (Units), by Segment, 2018-2033
3.2.2 Intravascular Ultrasound Systems (IVUS) Market, United States, Volume (Units), by Segment, 2018-2033
3.2.3 PTCA Balloon Catheters Market, United States, Volume (Units), by Segment, 2018-2033
3.2.4 Structural Heart Occlusion Devices Market, United States, Volume (Units), by Segment, 2018-2033
3.2.5 Transcatheter Accessories Market, United States, Volume (Units), by Segment, 2018-2033
3.3 Interventional Cardiology Market, United States, Average Price ($) , 2018-2033
3.4 Interventional Cardiology Market, United States, Company Share by Revenue ($m), 2024

4.1 Boston Scientific Corp
4.1.1 Company Overview
4.2 Abbott Laboratories
4.2.1 Company Overview
4.3 Terumo Corp
4.3.1 Company Overview
4.4 Medtronic Plc
4.4.1 Company Overview
4.5 Koninklijke Philips NV
4.5.1 Company Overview
4.6 Asahi Intecc Co Ltd
4.6.1 Company Overview
4.7 Shockwave Medical Inc
4.7.1 Company Overview
4.8 Teleflex Inc
4.8.1 Company Overview
4.9 W. L. Gore & Associates Inc
4.9.1 Company Overview
4.10 AtriCure Inc
4.10.1 Company Overview

6.1 Venture Financing
6.1.1 Okami Medical Raises USD32.5 Million in Venture Financing

7.1 Corporate Communications
7.1.1 Jul 08, 2025: Medtronic Appoints Chad Spooner as Chief Financial Officer of MiniMed
7.1.2 May 21, 2025: Medtronic Announces Leadership Change in Cardiovascular Portfolio
7.1.3 Feb 18, 2025: Orchestra BioMed Appoints Vivek Reddy, M.D. as Executive Chairman of the BACKBEAT Study Steering Committee and Chairman of Bioelectronic Therapies Scientific Advisory Board
7.2 Financial Announcements
7.2.1 Sep 02, 2025: Boston Scientific Announces 2025 Investor Day Meeting and Conference Call Discussing Third Quarter 2025 Results
7.2.2 Jul 30, 2025: AtriCure Reports Second Quarter 2025 Financial Results; Raises Financial Outlook for 2025
7.2.3 Jul 03, 2025: Merit Medical Systems To Announce Second Quarter 2025 Results On July 30, 2025
7.2.4 Mar 19, 2025: AngioDynamics to Report Fiscal 2025 Third Quarter Financial Results on April 2, 2025 and Host Virtual Cardiovascular Investor Event
7.2.5 Jan 13, 2025: AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2024, Provides Financial Outlook for 2025, and Announces Upcoming Analyst & Investor Day
7.2.6 Jan 08, 2025: AngioDynamics Reports Fiscal Year 2025 Second Quarter Financial Results
7.2.7 Dec 19, 2024: AngioDynamics to Report Fiscal 2025 Second Quarter Financial Results on January 8, 2025 and Host Virtual NanoKnife Investor Event
7.2.8 Oct 23, 2024: Boston Scientific Reports Results for Q3 2024
7.2.9 Oct 08, 2024: Merit Medical Systems to Announce Third Quarter 2024 Results on October 30, 2024
7.2.10 Oct 08, 2024: AtriCure to Announce Third Quarter 2024 Financial Results
7.2.11 Oct 03, 2024: AngioDynamics Announces Fiscal Year 2025 Q1 Results
7.2.12 Oct 02, 2024: Boston Scientific Announces Conference Call Discussing Third Quarter 2024 Results
7.2.13 Sep 26, 2024: Integer Schedules Third Quarter 2024 Earnings Release and Conference Call for October 24, 2024
7.3 Government and Public Interest
7.3.1 Aug 20, 2025: AtriCure to Participate in the 2025 Wells Fargo Healthcare Conference
7.3.2 Aug 12, 2025: Integer to Present at 2025 Wells Fargo Healthcare Conference on Sept. 4
7.3.3 Jul 30, 2025: Artivion to Participate in Upcoming Investor Conferences
7.3.4 Jul 28, 2025: AtriCure to Participate in the Canaccord Genuity 45th Annual Growth Conference
7.3.5 Jun 19, 2025: Mah Sing Healthcare Sdn Bhd Receives 510(K) Clearance For Nitrile Powder Free Examination Glove with Tremella Fuciformis Extract
7.3.6 May 01, 2025: Boston Scientific Announces Upcoming Investor Conference Schedule
7.3.7 Apr 24, 2025: Mabwell To Present Clinical Data of 9mw2821 Combined With Toripalimab in Patients With UC in an Oral Presentation at 2025 ASCO
7.3.8 Mar 10, 2025: AngioDynamics to Present at the Oppenheimer 35th Annual Healthcare MedTech and Services Virtual Conference
7.3.9 Jan 13, 2025: AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2024, Provides Financial Outlook for 2025, and Announces Upcoming Analyst & Investor Day
7.3.10 Dec 19, 2024: AngioDynamics to Report Fiscal 2025 Second Quarter Financial Results on January 8, 2025 and Host Virtual NanoKnife Investor Event
7.3.11 Nov 21, 2024: Trawick International Enhances Global Medical Coverage with Access to Cleveland Clinic World-Renowned Care
7.4 Legal And Regulatory
7.4.1 Aug 28, 2025: CNC Technologies Receives 510(K) Clearance For Duoblade Prime
7.4.2 Apr 01, 2025: Domain Therapeutics To Present Data on DT-9081 at AACR Annual Meeting 2025
7.4.3 Dec 09, 2024: Karolinska Development's Portfolio Company Modus Therapeutics Initiates a Phase 2 Study with Sevuparin for Treatment of CKD with Anemia
7.4.4 Nov 19, 2024: Botanix presentation at Bell Potter Healthcare Conference
7.5 Other Significant Developments
7.5.1 Aug 13, 2025: Positron Secures Multi-Unit Sale of PET-CT Scanners to Leading Cardiology Group
7.5.2 Jan 08, 2025: AngioDynamics Reports Fiscal Year 2025 Second Quarter Financial Results
7.6 Product News
7.6.1 Jun 30, 2025: InterShunt Enrolls First Patient in New Heart Failure Study
7.6.2 May 31, 2025: Daiichi Sankyo : ENHERTU Reduced the Risk of Death by 30% Versus Ramucirumab Plus Paclitaxel in Patients with Gastric Cancer in Phase 3 Trial
7.6.3 Mar 04, 2025: Micreos Pharmaceuticals Partners With Biologics CDMO Northway Biotech for Its Engineered Endolysin Therapeutic Manufacturing Program
7.6.4 Dec 09, 2024: Lomond Reports Results From Ongoing Clinical Studies of Lonitoclax, a Selective Bcl-2 Inhibitor in the Treatment of CLL and AML
7.6.5 Dec 02, 2024: ProLynx Announces Publication of Its Once Monthly Semaglutide in the Proceedings of the National Academy of Sciences

8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Market Modeling and Forecasting
8.1.5 Company Share Analysis
8.1.6 Benchmarking
8.2 the analyst Consulting
8.3 Contact the Publisher
8.4 Disclaimer

Table 1: Interventional Cardiology Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 2: Coronary Stents Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 3: Intravascular Ultrasound Systems (IVUS) Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 4: PTCA Balloon Catheters Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 5: Structural Heart Occlusion Devices Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 6: Transcatheter Accessories Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 7: Interventional Cardiology Market, United States, Volume (Units), 2018-2033
Table 8: Coronary Stents Market, United States, Volume (Units), 2018-2033
Table 9: Intravascular Ultrasound Systems (IVUS) Market, United States, Volume (Units), 2018-2033
Table 10: PTCA Balloon Catheters Market, United States, Volume (Units), 2018-2033
Table 11: Structural Heart Occlusion Devices Market, United States, Volume (Units), 2018-2033
Table 12: Transcatheter Accessories Market, United States, Volume (Units), 2018-2033
Table 13: Interventional Cardiology Market, United States, Average Price ($), 2018-2033
Table 14: Interventional Cardiology Market, United States, Company Share by Revenue ($m), 2024
Table 15: Interventional Cardiology Market Pipeline Products
Table 16: Okami Medical Raises USD32.5 Million in Venture Financing
Table 17: Total Number of Primary Research Participants, Cardiovascular devices Market, by Country

Figure 1: Interventional Cardiology Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 2: Coronary Stents Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 3: Intravascular Ultrasound Systems (IVUS) Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 4: PTCA Balloon Catheters Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 5: Structural Heart Occlusion Devices Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 6: Transcatheter Accessories Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 7: Interventional Cardiology Market, United States, Volume (Units), 2018-2033
Figure 8: Coronary Stents Market, United States, Volume (Units), 2018-2033
Figure 9: Intravascular Ultrasound Systems (IVUS) Market, United States, Volume (Units), 2018-2033
Figure 10: PTCA Balloon Catheters Market, United States, Volume (Units), 2018-2033
Figure 11: Structural Heart Occlusion Devices Market, United States, Volume (Units), 2018-2033
Figure 12: Transcatheter Accessories Market, United States, Volume (Units), 2018-2033
Figure 13: Interventional Cardiology Market, United States, Company Share (%), 2024